Dr. Ipek Alpertunga, MD

  • Danbury, CT
  • Endocrinologist
NPI1386166452PAC ID1153689336
Medicare services, 2024
171
Medicare patients, 2024
85
Part D claims, 2024
699
MIPS score, 2024
90
Hospital affiliations
4
Practice address
100 Reserve Rd, Danbury, CT 06810
Practice phone
Call (203) 739-7742
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Nuvance Health Medical Practice CT, Inc.

Danbury, Connecticut

See all 10 affiliations

Find Dr. Alpertunga's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ipek Alpertunga is an endocrinologist in Danbury, Connecticut

Dr. Alpertunga practices at Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut.

Dr. Alpertunga's NPI, 1386166452, was assigned on July 11, 2017. Dr. Alpertunga holds Connecticut license 069449.

NPI and contact details
Medicare PAC ID
1153689336
NPI enumeration date
July 11, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(203) 739-7742
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ipek Alpertunga practices at Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut

Dr. Alpertunga's primary practice is Nuvance Health Medical Practice CT, Inc., at 100 Reserve Rd, Danbury, CT 06810 in Western Ct County. The practice phone is (203) 739-7742.

  • Nuvance Health Medical Practice CT, Inc.
    100 Reserve Rd, Danbury, CT 06810 · Western Ct CountyPhone(203) 739-7742

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Ipek Alpertunga is affiliated with 7 sites of care and 3 medical groups

Dr. Alpertunga's primary practice is Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut. Dr. Alpertunga is also affiliated with Northwell Danbury Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Alpertunga to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

See all 10 affiliations for Dr. Alpertunga

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Ipek Alpertunga's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alpertunga practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Nuvance Health Medical Practice CT, Inc.Available with a free account
+6 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Alpertunga practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ipek Alpertunga is one of 188 endocrinologists in Connecticut

Endocrinology, diabetes and metabolism is Dr. Alpertunga's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Alpertunga is licensed in Connecticut.

Specialties and state licenses

  • Endocrinology, diabetes and metabolism, ConnecticutPrimaryLicense 069449 · taxonomy 207RE0101X

Endocrinologists near Dr. Alpertunga

Counts of endocrinologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ipek Alpertunga billed Medicare for 171 services in 2024

CMS data shows 171 Medicare services from Dr. Alpertunga across 4 procedure codes in 2024, for 85 Medicare patients. Medicare paid $12,068 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024171
Medicare patients85
Paid by Medicare$12,068
Procedure codes4

Dr. Alpertunga's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2062024: 14928%
Tests and treatments
2023: 162024: 2238%

Dr. Alpertunga compared with the Connecticut median for endocrinologists, 2024

  • Dr. Alpertunga
  • Connecticut median
Medicare services
171vs 45763% below
Medicare patients
85vs 21360% below
Part D claims
504vs 1,32762% below

Medians across 179 endocrinologists in Connecticut with Dmand AI profiles that report each measure.

Dr. Alpertunga's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Alpertunga

Need commercial claims for Dr. Alpertunga?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alpertunga and other endocrinologists in Connecticut.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ipek Alpertunga treated 85 Medicare patients in 2024, average age 69

CMS counts 85 Medicare patients who saw Dr. Alpertunga in 2024. The largest group is under 65, with 28 patients. 75% of them have diabetes, and 75% have high blood pressure. 53% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alpertunga's median patient age at 59, with 78% women.

Medicare patients, 202485
Average age69
Average risk score2.75
Also on Medicaid53%

Dr. Alpertunga's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Alpertunga's Medicare patients by sex, 2024

  • Women4452%
  • Men4148%

Chronic conditions among Dr. Alpertunga's Medicare patients, 2024

  1. Diabetes75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Chronic kidney disease52%
  5. Heart failure51%
  6. Ischemic heart disease49%
  7. Mood disorders48%
  8. Anxiety44%

Share of Medicare patients with each condition. A patient can have several.

Dr. Alpertunga's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 59

Patient panel by sex, all payers

  • Women78%
  • Men20%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ipek Alpertunga wrote 699 Medicare Part D claims in 2024

In 2024, Dr. Alpertunga wrote 699 Medicare Part D claims for 127 patients. 21% of them were for generic drugs. CMS names the drug for 504 of them, across 18 drugs with 11 or more claims each, at $328,618 in total drug cost. In 2023, CMS named 383 claims across 14 drugs.

Part D claims, 2024699
Drugs named by CMS18
Total drug cost$328,618
Part D patients127

Dr. Alpertunga's Part D claims by kind of drug, 2024

  • Generic146 claims21%
  • Brand-name429 claims61%
  • Other124 claims18%

Dr. Alpertunga's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3832024: 50432%

Drugs named by CMS: 18 in 2024, 14 in 2023.

See all prescribing by Dr. Alpertunga

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Ipek Alpertunga scored 90 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Alpertunga for performance year 2024, reported as part of a group. Dr. Alpertunga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alpertunga as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Alpertunga's MIPS scores, performance year 2024

  • 90of 100Final score
  • 83.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find endocrinologists like Dr. Alpertunga by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ipek Alpertunga received $1,402 in industry payments from 2022 to 2025

CMS Open Payments shows 63 general payments to Dr. Alpertunga from 14 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $231.

General payments to Dr. Alpertunga by program year, 2022 to 2025

Companies that paid Dr. Alpertunga the most, 2022 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Alpertunga

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Ipek Alpertunga's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ipek Alpertunga

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ipek Alpertunga's NPI number?

Dr. Ipek Alpertunga's NPI number is 1386166452. It was assigned on July 11, 2017, and it is active in the NPI Registry.

What kind of doctor is Dr. Ipek Alpertunga?

Dr. Ipek Alpertunga is an endocrinologist in Danbury, Connecticut. The primary specialty in the NPI Registry is Endocrinology, Diabetes & Metabolism Physician (taxonomy code 207RE0101X).

Where does Dr. Ipek Alpertunga practice?

Dr. Alpertunga practices at 100 Reserve Rd, Danbury, CT 06810. Dr. Alpertunga's primary practice is Nuvance Health Medical Practice CT, Inc. in Danbury, Connecticut. Dmand AI also links Dr. Alpertunga to 3 hospitals, 2 group practices and clinics and 2 medical groups.

What is Dr. Ipek Alpertunga's office phone number?

The practice phone on file for Dr. Alpertunga is (203) 739-7742.

What is Dr. Ipek Alpertunga's medical license number?

Dr. Alpertunga holds Connecticut license 069449.

Which hospitals is Dr. Ipek Alpertunga affiliated with?

Dr. Alpertunga is affiliated with Northwell Danbury Hospital. Dmand AI links Dr. Alpertunga to 3 more hospitals.

What medical group is Dr. Ipek Alpertunga part of?

Dr. Alpertunga is linked to Hartford HealthCare Medical Group Specialists. Dmand AI links Dr. Alpertunga to 2 more medical groups.

Does Dr. Ipek Alpertunga accept Medicare?

Yes. CMS data shows Dr. Alpertunga billed Medicare for 171 services in 2024, and Dr. Alpertunga accepts Medicare assignment.

Does Dr. Ipek Alpertunga offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Alpertunga as offering telehealth services.

What is Dr. Ipek Alpertunga's MIPS score?

Dr. Alpertunga's MIPS final score for performance year 2024 is 90 out of 100, reported as part of a group.

Show 5 more questionsShow fewer questions

How many Medicare patients does Dr. Ipek Alpertunga see?

CMS counts 85 Medicare patients who saw Dr. Alpertunga in 2024, with an average age of 69.

What services does Dr. Ipek Alpertunga bill to Medicare?

In 2024, Dr. Alpertunga's most billed Medicare services were hospital inpatient care (99232), office visit, established patient (99214) and hospital inpatient care (99222).

What drugs does Dr. Ipek Alpertunga prescribe most?

In 2024 Medicare Part D data, Dr. Alpertunga's most prescribed drugs by claims were Mounjaro, Omnipod 5 Dexg7g6 Pods (Gen 5) and Levothyroxine Sodium.

Has Dr. Ipek Alpertunga received payments from drug or device companies?

CMS Open Payments shows $1,402 in general payments to Dr. Alpertunga from 14 companies from 2022 to 2025. The largest total came from Amgen Inc.

How long has Dr. Ipek Alpertunga been practicing?

Dr. Alpertunga graduated from medical school in 2016, 10 years ago.

Selling to endocrinology, diabetes and metabolism practices?

See endocrinologists in Connecticut by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)